Check out our most popular compounded medications! Get Started
Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free) are designed to treat conditions such as ADHD, Narcolepsy, Depression, Bipolar Disorder, and Attention Deficit Hyperactivity Disorder. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile. Importantly, this formulation is gluten-free, catering to those with specific dietary requirements.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to offer Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free), a compounded formulation designed to provide a controlled and prolonged release of the active ingredient, methylphenidate HCl. This medication is primarily used in the treatment of ADHD, Narcolepsy, Attention Deficit Disorder, Depression, and Bipolar Disorder.
Methylphenidate HCl is a stimulant medication that works by increasing the levels of dopamine and norepinephrine in the brain. This helps to improve focus, concentration, and alertness, and can also help to reduce impulsivity and hyperactivity, which are common symptoms of the aforementioned conditions.
The slow release formulation of Methylphenidate HCl 10 mg is compounded with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period of time, offering sustained therapeutic effects. This not only enhances the effectiveness of the medication but also reduces the dosing frequency, thereby improving patient compliance.
Furthermore, this formulation is gluten-free, making it a suitable option for patients with gluten sensitivities or celiac disease. This is part of our commitment to providing personalized medication solutions that cater to the unique needs and preferences of our patients.
If you have any questions about Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free) or any of our other compounded formulations, please do not hesitate to contact us. Our team of compounding pharmacists is always ready to provide the necessary guidance and support.
This compounded formulation of Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free) is specifically designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Attention Deficit Disorder (ADD), Depression, and Bipolar Disorder. Methylphenidate, the active ingredient, is a central nervous system stimulant that functions by augmenting the quantity of certain natural substances in the brain, which are essential for controlling behavior and attention.
It is crucial to understand that Methylphenidate should not be used as a remedy for tiredness or to delay sleep in individuals who do not have a sleep disorder. Furthermore, Methylphenidate may interact with other medications, including monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and other stimulants. Therefore, it is vital to inform your healthcare provider about all other medications, vitamins, and herbs you are currently taking before initiating treatment with Methylphenidate.
Patients should be cognizant of the potential side effects of Methylphenidate, which may include decreased appetite, difficulty sleeping, headache, stomachache, and weight loss. If you experience any of these side effects, it is important to consult with your healthcare provider. Additionally, Methylphenidate should not be used in conjunction with alcohol or other drugs that can induce drowsiness. It is also worth noting that Methylphenidate may cause an increase in blood pressure and heart rate.
If you have any queries about this specific formulation of Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free) and its role in treating ADHD, Narcolepsy, Attention Deficit Disorder, Depression, and Bipolar Disorder, please do not hesitate to reach out for further information.
Methylphenidate HCl 10 mg Slow Release Capsules (Gluten Free) is a compounded formulation specifically designed to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Attention Deficit Disorder (ADD), Depression, and Bipolar Disorder. This medication functions by augmenting the levels of dopamine and norepinephrine in the brain, thereby enhancing focus, concentration, and alertness.
The unique feature of this formulation is its slow-release mechanism, achieved through the use of Methocel E4M, a type of controlled-release polymer. This technology ensures a gradual and sustained release of the active ingredient over an extended period, providing consistent therapeutic effects and reducing the need for frequent dosing. This prolonged release profile not only enhances the medication's efficacy but also improves patient compliance, particularly for those requiring a controlled and extended release of medication.
Another significant aspect of this formulation is its gluten-free nature, making it an appropriate choice for individuals with gluten sensitivities or allergies. This ensures that the medication is accessible and safe for a wider range of patients, catering to their specific dietary needs and restrictions.
When using Methylphenidate HCl 10 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider. The medication should be taken as prescribed, not exceeding the recommended frequency. Consistency is key, so taking the medication at the same time each day will ensure a steady relief of symptoms. It is also advisable to avoid combining this medication with alcohol or other medications that may interact adversely with it.
If you have any queries or concerns about this formulation or its mechanism of action, please do not hesitate to contact your healthcare provider.
Methylphenidate HCl 10 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of this medication. It is designed to release the encapsulated medication gradually over an extended period of time.
Yes, Methylphenidate HCl 10 mg Slow Release Capsules is a gluten-free medication.
Due to its slow release formulation, the dosing frequency of Methylphenidate HCl 10 mg Slow Release Capsules is reduced. However, the exact dosing schedule should be determined by your healthcare provider.
The therapeutic effects of Methylphenidate HCl 10 mg Slow Release Capsules are sustained over an extended period of time due to its slow release formulation. This medication is typically used to treat conditions like ADHD.
Yes, the slow release formulation of Methylphenidate HCl 10 mg Slow Release Capsules is designed to improve patient compliance by reducing the dosing frequency.
Methylphenidate HCl 10 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It is important to discuss your medical history and current medications with your provider before starting this medication.
A controlled and prolonged release profile refers to the way in which the medication is released into the body. In this case, the medication is released gradually over an extended period of time, providing a steady level of the drug in the body.
It's important to discuss all your current medications with your healthcare provider before starting Methylphenidate HCl 10 mg Slow Release Capsules. Some medications may interact with Methylphenidate, affecting its effectiveness or causing side effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
